RSR13 FDA Approval Status
FDA Approved: No
Brand name: RSR13
Generic name: efaproxiral
Company: Allos Therapeutics, Inc.
Treatment for: Brain Metastases in patients with Breast Cancer
Development timeline for RSR13
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.